Our Chief Scientific Officer recently served as a scientific reviewer for the Peer Reviewed Cancer Research Program (PRCRP).
David R. Hurwitz, PhD, our Richard B. Ross Chief Scientific Officer, recently served as a scientific reviewer for the Peer Reviewed Cancer Research Program (PRCRP) in Washington, DC. He was chosen to be part of this prestigious expert panel to help determine recipients of the Synergistic Idea Award for Pediatric Brain Tumor Research. This initiative is part of the Department of Defense Congressionally Directed Medical Research Programs.
The goal of the PRCRP is to improve quality of life by significantly decreasing the impact of cancer on service members, their families, and the American public. The organization fosters groundbreaking research, team science, and partnerships for the development of better prevention against, earlier detection of, and more effective treatments for cancer. The PRCRP program designated $2 million for research of pediatric brain tumors within the4 field of childhood cancer.
"It was an honor to serve on this panel, and an opportunity to learn more about cutting edge directions in the field of pediatric brain tumor research," said Dr. Hurwitz. "Engaging in analytical scientific discussions with some of the nation’s top researchers is always helpful as NTBS continues its drive to provide answers to the challenges of pediatric brain tumors."
Working with leading pediatric researchers, Dr. Hurwitz introduced the NBTS Pediatric Research Initiative in 2009. This initiative lays out the blueprint for NBTS' research focus in this research area.
Among his responsibilities at the two-day event was serving as a “first scientist reviewer” with the role of describing the proposed research in applications and presenting the strengths and weaknesses of submissions.